Identifying Upside Potential In XLV
by Mike Paulenoff
September 2, 2024 • 5:54 PM EDT
On August 15, with XLV (Healthcare SPDR, ETF) approaching Mike Paulenoff's target zone (noted in an April 18th post), Mike responded to an MPTrader member's question about whether it was "time to sell and find something with more potential?"
Mike wrote: "My short answer: no, it is not yet time to sell (although I will never dissuade anyone from taking profits and from ringing the cash register). My pattern and momentum work argue that upside potential extends from 156 to 161. That said, any bout of weakness that presses and closes beneath 148 will neutralize my current outlook. Bottom Line: Unless XLV reverses this week's upmove by declining beneath 148 (down about 2.5%), the current setup projects to a minimum upside target of 156 and a maximum target of 161... Last is 152.26 (8/15/24)..."
Fast-forward to this past Wednesday August 28: XLV had climbed to a new ATH of 156.44, which pushed the price structure into the lower boundary of Mike's optimal upside target zone of 156-161.
As Mike explained to members that day, with XLV trading at 155.79, "This also means it is time to be cautious about any forthcoming weakness that breaks and sustains below 154.00, the level that triggers an initial warning signal that the post-April upleg from 138.41 to 154.66 is exhausted and vulnerable to a meaningful correction."
XLV closed last week at higher ATHs of 157.20. From the time of Mike's original post to members on April 18 at 138.46, XLV has climbed 13.5%.
What's next for XLV and the healthcare sector, in general? Login this week to join Mike and our MPTrader community for ongoing discussions about the opportunistic technical setups and fundamental inputs on healthcare as well as many individual stocks, sector ETFs, macro indices, currencies, commodities, and Bitcoin.
Mike Paulenoff is the author of MPTrader.com, a real-time diary of his technical analysis & trade alerts
on
ETFs for precious metals, energy, currencies, and an array of equity indices and sectors, including
international
markets, plus key ETF component stocks in sectors like technology, mining, and banking.
Sign up for a Free 7-day Trial!
More Top Calls From Mike
Last Tuesday afternoon, hours before CAVA (Cava Group) was scheduled to report Earnings, this is what I posted for MPTrader members:CAVA reports Earnings after today's close. Approaching the news, CAVA is circling 61, a full 40% beneath its April 2026 high at 98.79, amid an unconfirmed new corrective low at 60.21 yesterday (8/10/26), leaving CAVA positioned for a "buy-the-news" setup (the opposite of a sell-the-news setup in a name that is up 30% to 40% approaching Earnings).
Good Sunday Afternoon, MPTraders! Last Thursday afternoon, ahead of AAPL's Earnings, this is what we discussed about the stock's probable price path in reaction to the news:Unless AAPL produces something extraordinary, or otherwise announces some unknown bullish catalyst, my pattern work has a very difficult time expecting anything other than a "best-case" sell-the-news scenario in reaction to Earnings. I can make a compelling argument that the upleg from the 6/26/26 low at 273.33 to the 7/29/26 ATH at 344.
XOM (Exxon Mobil)-- Back on May 19, 2026, a fellow MPTrader member requested an update on XOM. This is what we discussed at that time:My attached Daily Chart setup shows my preferred scenario calling for a near-term peak of the current upmove from the 4/17 low at 141.97 to a target zone from 162 to 165, followed by a rollover and press lower that revisits and possibly breaks the 41/7 low, which also will complete the larger corrective process from the 3/30/26 ATH at 176.41.
Pharma Update: MRK and LLYOn Wednesday (6/24/26), this is what we discussed about MRK:MRK as well, which we see on my attached Daily Chart exhbits a VERY BULLISH technical setup-- quite the opposite of beleaguered PFE. My pattern work argues that all of the price action from the 2/25/26 high at 125.14 represents a high-level bullish digestion period and pattern atop the major upleg from the May 2025 low at 73.31.
On January 2, 2026, this is what I posted about CAVA (Cava Group Casual Mediterranean Cuisine) to MPTrader members:After CAVA's meteoric climb from 29.00 in October 2023 to an ATH at 172.65 in November 2024, the stock rolled over into a relentless decline that hit its low at 43.